Skip to content

DYNADERM: what changed

BE 0479.019.949NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€11,782
2024 · €14,962-€26,744
Equity
€22,050
2024 · €33,832-€11,782
Cash
€130
2024 · €579-€449
Balance sheet total
€47,613
2024 · €72,285-€24,672

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€24,223

    down €24,223 (-33.8%), from €71,706 to €47,483

    of which Other amounts receivable: -€29,170

Equity and liabilities
  • Other debts -€14,392

    down €14,392 (-95.9%), from €15,000 to €608

  • Profit (loss) carried forward -€11,782

    down €11,782 (-77.3%), from €15,232 to €3,450

  • Trade debts +€6,830

    up €6,830 (+45.6%), from €14,987 to €21,816

  • Tax, wage and social debts -€5,327

    down €5,327 (-62.9%), from €8,466 to €3,139

    of which Taxes: -€4,527

Income statement
  • Gross operating margin -€23,626

    down €23,626, from €19,520 to -€4,105

  • Taxes +€2,905

    up €2,905 (+51.4%), from €5,649 to €8,554

  • Financial income -€828

    down €828 (-25.2%), from €3,282 to €2,453

  • Other operating charges -€568

    down €568 (-53.5%), from €1,061 to €493

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €14,962
Gross operating margin -€23,626
Other operating charges +€568
Financial income -€828
Financial charges +€47
Taxes -€2,905
Result 2025 -€11,782
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€449
Investment €0
Financing €0
Cash 2024 €579
Net result for the year -€11,782
Receivables within one year +€24,223
Trade debts +€6,830
Tax, wage and social debts -€5,327
Other debts -€14,392
Cash 2025 €130
brings cash intakes cash out
Every line side by side 31 lines
Line Code 2024 2025 Change %
Total assets 20/58 €72,285 €47,613 -€24,672 -34.1%
Current assets 29/58 €72,285 €47,613 -€24,672 -34.1%
Amounts receivable within one year 40/41 €71,706 €47,483 -€24,223 -33.8%
Trade receivables 40 €9,202 €14,150 +€4,947 +53.8%
Other amounts receivable 41 €62,504 €33,334 -€29,170 -46.7%
Cash at bank and in hand 54/58 €579 €130 -€449 -77.6%
Total equity and liabilities 10/49 €72,285 €47,613 -€24,672 -34.1%
Equity 10/15 €33,832 €22,050 -€11,782 -34.8%
Contributions 10/11 €18,600 €18,600 = 0.0%
Contributions outside capital 11 €18,600 €18,600 = 0.0%
Other 1109/19 €18,600 €18,600 = 0.0%
Profit (loss) carried forward 14 €15,232 €3,450 -€11,782 -77.3%
Amounts payable 17/49 €38,453 €25,563 -€12,890 -33.5%
Amounts payable within one year 42/48 €38,453 €25,563 -€12,890 -33.5%
Trade debts 44 €14,987 €21,816 +€6,830 +45.6%
Suppliers 440/4 €14,987 €21,816 +€6,830 +45.6%
Taxes, remuneration and social security 45 €8,466 €3,139 -€5,327 -62.9%
Taxes 450/3 €7,666 €3,139 -€4,527 -59.1%
Remuneration and social security 454/9 €800 - -€800
Other amounts payable 47/48 €15,000 €608 -€14,392 -95.9%
Other operating charges 640/8 €1,061 €493 -€568 -53.5%
Gross operating margin 9900 €19,520 -€4,105 -€23,626
Operating profit (loss) 9901 €18,459 -€4,598 -€23,058
Financial income 75/76B €3,282 €2,453 -€828 -25.2%
Recurring financial income 75 €3,282 €2,453 -€828 -25.2%
Financial charges 65/66B €1,130 €1,083 -€47 -4.1%
Recurring financial charges 65 €1,130 €1,083 -€47 -4.1%
Profit (loss) for the period before taxes 9903 €20,611 -€3,228 -€23,839
Income taxes 67/77 €5,649 €8,554 +€2,905 +51.4%
Profit (loss) for the period 9904 €14,962 -€11,782 -€26,744
Profit (loss) for the period to be appropriated 9905 €14,962 -€11,782 -€26,744

Value

latest balance sheet 30-09-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€39,497 to €50,885

Midpoint €44,242 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €22,050
Capitalised earnings €56,943 to €79,720
Indication €39,497 to €50,885

Adjusted equity

balance sheet 30-09-2025
Equity (10/15)
€22,050
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€22,050

Capitalised earnings

net result for the year (9904)
2025
-€11,782
2024
€14,962
2023
€20,735
2022
€25,237
2021
€13,043
Average result
€7,972
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€56,943 / €66,433 / €79,720

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.